This inventor holds 6 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: University of California, University College Dublin, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:






Years Active: 2018-2026
Title: John Vincent Fahy: Innovator in Mucolytic Agents
Introduction
John Vincent Fahy is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of mucolytic agents, holding a total of 6 patents. His work focuses on methods to improve respiratory health by decreasing mucus viscosity and elasticity.
Latest Patents
Fahy's latest patents include innovative formulations and methods for mucolytic agents. One of his patents, titled "Dithiolsaccharide mucolytic agents and uses thereof," provides methods for decreasing mucus elasticity or viscosity in subjects. This involves administering an effective amount of a dithiolsaccharide mucolytic agent. Another significant patent is for "Thiosaccharide mucolytic agents," which similarly aims to reduce mucus viscosity through the administration of thiosaccharide mucolytic agents.
Career Highlights
Throughout his career, Fahy has worked with prestigious institutions such as the University of California and University College Dublin. His research has contributed to advancements in respiratory therapies and has had a positive impact on patient care.
Collaborations
Fahy has collaborated with notable colleagues, including Stefan Oscarson and Shaopeng Yuan. Their combined expertise has furthered the development of effective mucolytic treatments.
Conclusion
John Vincent Fahy is a distinguished inventor whose work in mucolytic agents has the potential to improve respiratory health significantly. His innovative patents and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile